News

Ever smaller batches for individual therapeutic approaches, new cost-intensive biopharmaceuticals, and the Covid-19 pandemic are currently changing the pharmaceutical industry more rapidly than ever before. Syntegon Technology showcases solutions to these challenges at the virtual ACHEMA Pulse from June...

Gamma Biosciences, a global life sciences company serving the advanced therapy market, announced that it has agreed to make a controlling investment in Mirus Bio, an innovator and developer of biomimetic, cell-adaptive lipid-polymer nanocomplexes (LPNCs) for nucleic acid delivery...

President Biden, heeding widespread calls to step up his response to the pandemic’s surge abroad, said on Monday that his administration would send 20 million doses of federally authorized coronavirus vaccine overseas in June — the first time he...

BD (Becton, Dickinson and Company), a leading global medical technology company, will build a €165 million ($200 million USD) high-tech manufacturing facility in city of Zaragoza, located in the Aragon region of Spain, that will create up to 600...

Natco Pharma Limited announced the signing of a royalty-free, non-exclusive, voluntary licensing agreement with Eli Lilly and Company, for the manufacture and commercialization of the drug baricitinib for Covid-19 indication in India. In line with the licensing agreement, Natco has...

Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced today that MTX-COVAB, its human-derived antibody against SARS-CoV-2, the virus that causes COVID-19, has shown efficacy against both the original virus as well as the...

Sharp, a part of UDG Healthcare and a leading provider of pharmaceutical packaging and clinical services, has appointed Robert O’Beirn as SVP and Managing Director of its global Clinical Services business. Mr O’Beirn joined UDG Healthcare ten years ago as...